In vitro retinoic acid release and skin permeation from different liposome formulations

International Journal of Pharmaceutics

Volumn 133, Issue 1-2, 1996, Pages 89-96

  Montenegro, Lucia ^a   Panico, Anna Maria ^a   Ventimiglia, Antonino ^a   Bonina, Francesco P ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Charged phospholipids; In vitro; Liposomes; Release; Retinoic acid; Skin permeation

Indexed keywords

LIPOSOME; PHOSPHOLIPID; RETINOIC ACID;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; DRUG RELEASE; EPIDERMIS; HUMAN; HUMAN TISSUE; PARTICLE SIZE; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; STRATUM CORNEUM; SURFACE CHARGE;

EID: 0029942199     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04422-1     Document Type: Article

References (28)

1. Bangham, A.D., Hill, M.W. and Miller, M.G.A., Preparation and use of liposomes as models of biological membranes. In Korn, E.D. (Ed.), Methods in Membrane Biology, Plenum Press, New York, 1974, pp. 56-61.
2. Barry, B.W., Dermatological Formulations. Dekker, New York, 1983.
3. Bonina, F.P. and Montenegro, L., Penetration enhancer effects on in vitro percutaneous absorption of heparin sodium salt. Int. J Pharm., 82 (1992) 171-177.
4. Bronaugh, R.L. and Stewart, R.F., Methods for in vitro percutaneous absorption studies. III: hydrophobic compounds. J. Pharm. Sci., 73 (1984) 1255-1258.
5. Burnette, R.R. and Ongipattanakul, B., Characterization of the permeselective properties of excised human skin during iontophoresis. J. Pharm. Sci., 76 (1987) 765-773.
6. Douglas, S.J., Illum, L., Davis, S.S. and Kreuter, J., Particle size distribution of poly(butyl-2-cyanoacrylate) nanoparticles:I. Influence of physicochemical factors. J. Colloid. Interface Sci., 101 (1984) 149-158.
7. Du Plessis, J., Ramachandran, C., Weiner, N. and Muller, D.G., The influence of particle size of liposomes on the deposition of drug into the skin. Int. J. Pharm., 103 (1994) 277-282.
8. Foldvari, M., Gesztes, A. and Mezei, M., Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J. Microencapsulation, 7 (1990) 479-489.
9. Foong, W.C., Harsany, B.B. and Mezei, M., Biodisposition and histological evaluation of topically applied retinoic acid in liposomal, cream and gel dosage forms. In: Hanin, I. and Pepeu, G. (Eds.), Phospholipids, Plenum Press, New York, 1990, pp. 279-282.
10. Franz, T.J., Percutaneous absorption. On the relevance of in vitro data. J. Invest. Dermatol., 67 (1975) 190-196.
11. Ganesan, M.G., Weiner, N.D., Flynn, G.L. and Ho, N.F.H., Influence of liposomal drug entrapment on percutaneous absorption. Int. J. Pharm., 20 (1984) 139-154.
12. Kligman, A.M. and Christophers, E., Preparation of isolated sheets of human skin. Arch. Dermatol., 88 (1963) 702-705.
13. Lehman, P.A., Slattery, J.T. and Franz, T.J., Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose. J. Invest. Dermatol., 91 (1988) 56-61.
14. Luxnat, M. and Galla, H., Partition of chlorpromazine into lipid bilayer membranes: the effect of membrane structure and composition. Biochim. Biophys. Acta, 856 (1986) 274-282.
15. Masini, V., Bonté, F., Meybeck, A. and Wepierre, J., In vitro percutaneous absorption and in vivo distribution of retinoic acid in liposomes and in a gel on hairless rats. Proc. Control. Rel. Bioact. Mater., 17 (1990) 425-426.
16. Masini, V., Bonté, F., Meybeck, A. and Wepierre, J., Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gels. J. Pharm. Sci., 82 (1993) 17-21.
17. Meybeck, A., Comedolytic activity of liposomal antiacne drug in an experimental model. In: Braun-Falco, O., Korting, H.C. and Maibach, H.I. (Eds.), Liposome Dermatics, Griesbahc Conference, Springer, Berlin, 1991, pp. 233-241.
18. Mezei, M., Liposomes as penetration promoters and localizers of topically applied drugs. In: Hsieh, D.S. (Ed.), Drug Permeation Enhancement, Dekker, New York, 1993, pp. 171-197.
19. Mueller, L.G., Novel anti-inflammatory esters, pharmaceutical compositions and methods for reducing inflammation. UK Patent GB 2 204 869A, 23 Nov., 1988.
20. Nastruzzi, C., Walde, P., Menegatti, E. and Gambari, R., Liposome associated retinoic acid increased in vitro antiproliferative effects on neoplastic cells. FEBS Lett., 259 (1990) 293-296.
21. Panico, A.M., Pignatello, R., Mazzone, S., Cardile, V., Bindoni, M., Cordopatri, F., Villari, A., Micali, N. and Mazzone, G., Lipid vesicles loaded with thymopentin: characterization and in vitro activity on tumoral cells. Int. J. Pharm., 98 (1993) 19-28.
22. 2 and T7: I. Light-scattering technique. Biochemistry, 13 (1974) 952-960.
23. Shah, V.P., Elkins, J., Lam, S.Y. and Skelly, J.P., Determination of in vitro drug release from hydrocortisone creams. Int. J. Pharm., 53 (1989) 53-59.
24. Shah, V.P. Elkins, J. and Skelly J.P., Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams. J. Pharm. Sci., 81 (1992) 55-59.
25. Shah V.P. and Skelly J.P., Practical considerations in developing a quality control (in vitro release) procedure for topical drug prodructs. In: Shah, V.P. and Maibach, H.I. (Eds.), Topical drug bioavailability, bioequivalence, and penetration, Plenum Press, New York, 1993, pp. 107-116
26. Suarat, J.H., Retinoids: new trends in Research and Therapy, Karger Press, New York, 1985, pp. 314-391.
27. Thibault, B. and Poelman, M.C., A new type of liposomes for topical use. Proc. 17th IFSCC Congress, Poster, 1992, pp. 245-250.
28. Touitou, E. and Fabin, B., Altered skin permeation of a highly lipophilic molecole: tetrahydrocannabinol. Int. J. Pharm., 43 (1988) 17-22.